| abstract |
The present invention provides novel pharmaceutical compositions of a compound of formula (I) or a pharmaceutically acceptable salt thereof: It is suitable for the mass manufacture of oral pharmaceutical dosage forms; methods for producing the oral pharmaceutical dosage forms; and the use of the pharmaceutical compositions for the treatment of patients suffering from or suffering from a disease, disorder or condition involving Cell survival, proliferation and migration, including chronic inflammatory proliferative disorders, proliferative ocular disorders, benign proliferative disorders and cancer. |